BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 31839726)

  • 1. A case of IgE myeloma transformed into IgE-producing plasma cell leukaemia.
    Galakhoff N; Leven C; Eveillard JR; Tempescul A; Kerspern H; Aubron C; Buors C; Lippert É; Carré JL; Padelli M
    Biochem Med (Zagreb); 2020 Feb; 30(1):010801. PubMed ID: 31839726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rare case of IgE kappa monoclonal gammopathy of undetermined significance identified in a Swedish female.
    Fager Ferrari M; Lemonakis K; Förnvik Jonsson M
    Scand J Clin Lab Invest; 2021 Sep; 81(5):385-388. PubMed ID: 34097568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elimination of the need for urine studies in the screening algorithm for monoclonal gammopathies by using serum immunofixation and free light chain assays.
    Katzmann JA; Dispenzieri A; Kyle RA; Snyder MR; Plevak MF; Larson DR; Abraham RS; Lust JA; Melton LJ; Rajkumar SV
    Mayo Clin Proc; 2006 Dec; 81(12):1575-8. PubMed ID: 17165636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Monoclonal gammopathies in a series of 1683 plasma donors].
    Tichý M; Rehácek V; Maisnar V; Dominiková K; Palicka V
    Cas Lek Cesk; 2004; 143(6):401-4; discussion 404. PubMed ID: 15309868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Free Light Chain Assay and κ/λ Ratio Performance in Patients Without Monoclonal Gammopathies:  High False-Positive Rate.
    Singh G
    Am J Clin Pathol; 2016 Aug; 146(2):207-14. PubMed ID: 27473738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low IgE monoclonal gammopathy level in serum highlights 20-yr survival in a case of IgE multiple myeloma.
    Hayes MJ; Carey JL; Krauss JC; Hedstrom DL; Gulbranson RL; Keren DF
    Eur J Haematol; 2007 Apr; 78(4):353-7. PubMed ID: 17378894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple myeloma and multiple plasmacytomas associated with free gamma heavy chain, free kappa light chain and IgGk paraproteins: an unusual triple gammopathy.
    Deighan WI; O'Kane MJ; McNicholl FP; Keren DF
    Ann Clin Biochem; 2016 Nov; 53(6):706-711. PubMed ID: 27166317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Monoclonal Antibody Interference in Monoclonal Gammopathy Monitoring: a Denosumab Experience.
    Aydin O; Aykas F
    Lab Med; 2023 May; 54(3):e95-e97. PubMed ID: 36221992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum and Urine Protein Electrophoresis and Serum-Free Light Chain Assays in the Diagnosis and Monitoring of Monoclonal Gammopathies.
    Singh G
    J Appl Lab Med; 2020 Nov; 5(6):1358-1371. PubMed ID: 33150391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Free Light Chain Assay and κ/λ Ratio: Performance in Patients With Monoclonal Gammopathy-High False Negative Rate for κ/λ Ratio.
    Singh G
    J Clin Med Res; 2017 Jan; 9(1):46-57. PubMed ID: 27924175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment with bortezomib and dexamethasone for proliferative glomerulonephritis with monoclonal IgG deposits in multiple myeloma: a case report.
    Noto R; Kamiura N; Ono Y; Tabata S; Hara S; Yokoi H; Yoshimoto A; Yanagita M
    BMC Nephrol; 2017 Apr; 18(1):127. PubMed ID: 28385149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of serum immunofixation electrophoresis and free light chain assays in the detection of monoclonal gammopathies.
    Wood PB; McElroy YG; Stone MJ
    Clin Lymphoma Myeloma Leuk; 2010 Aug; 10(4):278-80. PubMed ID: 20709664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New patterns of relapse in multiple myeloma: a case of "light chain escape" in which FLC predicted relapse earlier than urine and serum immunofixation.
    Caldini A; Nozzoli C; Terreni A; Staderini M; Berardi M; Biagioli T; Brogi M; Bosi A
    Clin Chem Lab Med; 2016 Jun; 54(6):991-5. PubMed ID: 26581069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Polymerized Kappa Light Chain Multiple Myeloma.
    Biaz A; Fataki CM; Bagadema DCS; Lazreq F; Machtani-Idrissi SE; Kabbaj DE; Dami A; Bouhsain S
    Clin Lab; 2020 Dec; 66(12):. PubMed ID: 33337841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Kyle RA; San-Miguel JF; Mateos MV; Rajkumar SV
    Hematol Oncol Clin North Am; 2014 Oct; 28(5):775-90. PubMed ID: 25212882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urine Protein Immunofixation Electrophoresis: Free Light Chain Urine Immunofixation Electrophoresis Is More Sensitive than Conventional Assays for Detecting Monoclonal Light Chains and Could Serve as a Marker of Minimal Residual Disease.
    Singh G; Arinze N; Manthei DM; Plapp FV; Bollag RJ
    Lab Med; 2023 Sep; 54(5):527-533. PubMed ID: 36857478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum free light chains in clinical laboratory diagnostics.
    Jenner E
    Clin Chim Acta; 2014 Jan; 427():15-20. PubMed ID: 23999048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Free Light Chain Assay in Monoclonal Gammopathic Manifestations.
    Lee WS; Singh G
    Lab Med; 2019 Oct; 50(4):381-389. PubMed ID: 30957173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal gammopathy-associated proliferative glomerulonephritis.
    Sethi S; Rajkumar SV
    Mayo Clin Proc; 2013 Nov; 88(11):1284-93. PubMed ID: 24182705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice.
    Katzmann JA; Abraham RS; Dispenzieri A; Lust JA; Kyle RA
    Clin Chem; 2005 May; 51(5):878-81. PubMed ID: 15774572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.